Peptide mediators of cholesterol efflux
Patent
·
OSTI ID:1083792
The present invention provides a family of non-naturally occurring polypeptides having cholesterol efflux activity that parallels that of full-length apolipoproteins (e.g., Apo AI and Apo E), and having high selectivity for ABAC1 that parallels that of full-length apolipoproteins. The invention also provides compositions comprising such polypeptides, methods of identifying, screening and synthesizing such polypeptides, and methods of treating, preventing or diagnosing diseases and disorders associated with dyslipidemia, hypercholesterolemia and inflammation.
- Research Organization:
- LBNL (Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States))
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-05CH11231
- Assignee:
- The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 8,415,293
- Application Number:
- 12/999,966
- OSTI ID:
- 1083792
- Country of Publication:
- United States
- Language:
- English
Regulation and Mechanisms of ATP-Binding Cassette Transporter A1-Mediated Cellular Cholesterol Efflux
|
journal | July 2003 |
The complete genome sequence of Moorella thermoacetica (f. Clostridium thermoaceticum)
|
journal | July 2008 |
The C-Terminal Lipid-Binding Domain of Apolipoprotein E Is a Highly Efficient Mediator of ABCA1-Dependent Cholesterol Efflux that Promotes the Assembly of High-Density Lipoproteins
|
journal | March 2007 |
Similar Records
Potent and selective mediators of cholesterol efflux
Peptides having reduced toxicity that stimulate cholesterol efflux
Peptides having reduced toxicity that stimulate cholesterol efflux
Patent
·
Tue Mar 24 00:00:00 EDT 2015
·
OSTI ID:1174197
Peptides having reduced toxicity that stimulate cholesterol efflux
Patent
·
Tue Aug 16 00:00:00 EDT 2016
·
OSTI ID:1298004
Peptides having reduced toxicity that stimulate cholesterol efflux
Patent
·
Tue Jul 10 00:00:00 EDT 2018
·
OSTI ID:1463293